PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.

PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma. Abstract Text:

Cynthia E Wilkins-Port,Craig E Higgins,Jennifer Freytag,Stephen P Higgins,J Andrew Carlson,Paul J Higgins,

The emergence of highly aggressive subtypes of human cutaneous squamous cell carcinoma (SCC) often reflects increased autocrine/paracrine TGF-beta synthesis and epidermal growth factor receptor (EGFR) amplification. Cooperative TGF-beta/EGFR signaling promotes cell migration and induces expression of both proteases and protease inhibitors that regulate stromal remodeling resulting in acquisition of an invasive phenotype. TGF-beta1+EGF stimulation increases the production of several matrix metalloproteinases (MMPs) in human SCC. Among the most prominent is MMP-10 which is known to be elevated in SCC in situ. Activation of stromal plasminogen appears to be critical in triggering downstream MMP activity. Paradoxically, PAI-1, the major physiological inhibitor of plasmin generation, is also up-regulated under these conditions and is an early event in progression of incipient epidermal SCC. A model is proposed in which TGF-beta1+EGF-dependent MMP-10 elevation directs focalized matrix remodeling events that promote epithelial cell plasticity and tissue invasion. Increased PAI-1 expression serves to temporally and spatially modulate plasmin-initiated pericellular proteolysis, further facilitating epithelial invasive potential. Defining the complex signaling mechanisms that maintain this elegant balance is critical to developing potential therapeutics for the treatment of human cutaneous malignancies.

PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma. Publishing Authors By Initials

CE Wilkins-Port,CE Higgins,J Freytag,SP Higgins,JA Carlson,PJ Higgins,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of biomedicine & biotechnology

VOLUME: 2007

Page Numbers: 85208

Journal Abbreviation: J. Biomed. Biotechnol.

ISSN: 1110-7243

DAY: 20

MONTH: 03

YEAR: 2007

PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101135740

PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.

AFFILIATION: Center for Cell Biology and Cancer Research, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Biomed Biotechnol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma Related Publications

• A bifunctional O-GlcNAc transferase governs flagellar motility through anti-repression.
• A navigation aid for the blind using tactile-visual sensory substitution.
• Adeno-associated viral vector-encoding vascular endothelial growth factor gene: effect on cardiovascular MR perfusion and infarct resorption measurements in swine.
• Allele-specific binding of CTCF to the multipartite imprinting control region KvDMR1.
• Bean alpha-amylase inhibitors in transgenic peas inhibit development of pea weevil larvae.
• Comparing phenotypes in patients with idiopathic autism to patients with velocardiofacial syndrome (22q11 DS) with and without autism.
• Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media.
• Effects of elicitation task variables on speech production by children with cochlear implants.
• Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age.
• First inelastic neutron scattering studies on thin free standing polymer films.
• Gene expression, intron density, and splice site strength in Drosophila and Caenorhabditis.
• Genomic approaches to understanding bacterial virulence.
• Growth rate toxicity phenotypes and homeostatic supercoil control differentiate Escherichia coli from Salmonella enterica serovar Typhimurium.
• Impact of prenatal cocaine exposure on child behavior problems through school age.
• Microarray analysis of Mu transposition in Salmonella enterica, serovar Typhimurium: transposon exclusion by high-density DNA binding proteins.
• Mutational bias suggests that replication termination occurs near the dif site, not at Ter sites: what's the Dif?
• Opposing effects of 5-HT(2A) and 5-HT (2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test.
• Osteogenic protein-1 and related bone morphogenetic proteins regulate dendritic growth and the expression of microtubule-associated protein-2 in rat sympathetic neurons.
• PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.
• Patterns of sensitization to food and aeroallergens in the first 3 years of life.
• Progesterone receptor modulator for emergency contraception: a randomized controlled trial.
• Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.
• Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.
• Should we be CHARMed?
• System for the analysis and visualization of large 3D anatomical trees.
• The TGF-beta1/Upstream Stimulatory Factor-Regulated PAI-1 Gene: Potential Involvement and a Therapeutic Target in Alzheimer's Disease.
• The economic impact of reprocessing external fixation components.
• The impact of a genetics education program on physicians' knowledge and genetic counseling referral patterns.
• The use of heparin in preparing samples for blood-gas analysis.
• iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer.